Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 4,444,445 | 4,444,445 | 0 | $1.20B | $1.45B | 97.60% | +$249.20M |
| Intellia Therapeutics, Inc.(NTLA) | 3,702,995 | 3,702,995 | 0 | $26.33M | $34.73M | 2.34% | +$8.41M |
| Adicet Bio, Inc. | 968,183 | 968,183 | 0 | $731.0K | $590.6K | 0.04% | -$140.4K |
| Adverum Biotechnologies, Inc. | 180,909 | 180,909 | 0 | $790.6K | $389.0K | 0.03% | -$401.6K |
| 2seventy Bio, Inc. | 1,254,827 | 0 | -1,254,827 | $6.20M | $0 | — | -$6.20M |
| Bluebird Bio, Inc. | 21,000 | 0 | -21,000 | $102.5K | $0 | — | -$102.5K |